Skip to main content
OpenTrials

Clinical trial condition

Varicella Zoster Virus Infection

Explore clinical trials studying Varicella Zoster Virus Infection. Study availability and eligibility vary by location and protocol.

340 public trials 40 recruiting studies
Refine in advanced search Browse all conditions

Varicella Zoster Virus Infection trial results

Completed

Study to Evaluate the Impact of Reactogenicity on Quality of Life (QoL), After Administration of GlaxoSmithKline (GSK) Biologicals' Candidate Herpes Zoster Subunit (HZ/su) Vaccine (GSK1437173A) in Adults ≥ 50 Years of Age

NCT02979639

Conditions
DNA Virus Infections, Herpes Zoster, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Oakland, California, United States
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Colorado Springs, Colorado, United States
  • GSK Investigational Site Colorado Springs, Colorado, United States
View Trial Details
Completed

Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox

NCT00226499

Conditions
Chickenpox, Chickenpox Vaccines, DNA Virus Infections, +5 more
Locations
  • GSK Investigational Site Brno, Czechia
  • GSK Investigational Site Chomutov, Czechia
  • GSK Investigational Site Děčín, Czechia
  • GSK Investigational Site Havlíčkův Brod, Czechia
View all 104 locations
View Trial Details
Completed

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

NCT00802464

Conditions
Chickenpox, DNA Virus Infections, Herpes Zoster, +4 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Pembroke Pines, Florida, United States
  • GSK Investigational Site Las Vegas, Nevada, United States
  • GSK Investigational Site Edison, New Jersey, United States
View Trial Details

Related conditions